drugset / Trial / NCT00467896

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

NCT00467896

Phase 2 Terminated 62 enrolled Actelion
NaSingle-groupOpen-labelTreatment

Summary

A Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"

Timeline

Start
2006-09
Primary completion
2010-11
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified 5 ug Inhaled